Immediate Impact
22 from Science/Nature 71 standout
Citing Papers
Regulation of the cGAS-STING Pathway
2025 Standout
The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications
2025 Standout
Works of Maria Nirvana Formiga being referenced
A phase III randomized open label study comparing bempegaldesleukin (NKTR-214) plus nivolumab to sunitinib or cabozantinib (investigator's choice) in patients with previously untreated advanced renal cell carcinoma.
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Maria Nirvana Formiga | 177 | 137 | 111 | 39 | 341 | |
| Joanna Huszno | 142 | 183 | 122 | 34 | 406 | |
| Letterio Runza | 105 | 189 | 77 | 39 | 399 | |
| Mariola Iliszko | 184 | 119 | 115 | 27 | 356 | |
| Xiaochun Zhang | 173 | 80 | 117 | 30 | 351 | |
| Cormac Owens | 110 | 98 | 125 | 38 | 402 | |
| Kanae Nosaka | 130 | 151 | 176 | 35 | 410 | |
| Suryanarayana Deo | 87 | 134 | 67 | 35 | 386 | |
| Andri Papakonstantinou | 184 | 215 | 80 | 33 | 371 | |
| T Murakami | 145 | 72 | 61 | 41 | 372 | |
| C Brambilla | 124 | 178 | 101 | 29 | 393 |
All Works
Login with ORCID to disown or claim papers
Loading papers...